The role of screening for adverse drug effects, depression, and anxiety

Published: 18 Feb 2020
Views: 4452

Click the link to see a research article exploring how screening for adverse AED (Anti-Epileptic Drug) effects, depression and anxiety could improve quality of life for people with epilepsy.

 

The research was conducted using the following (summarised) method:

 

Patients were screened for quality of life (using QOLIE-31), major depressive disorder (MDD) (NDDI-E), generalised anxiety disorder (GAD) (GAD-7), and AED Effects (AEP). Then, dimensional (NDDI-E and GAD-7 scores) and categorical (MDD and GAD) analyses were performed to investigate interactions between quality of life and AED Effects.

Reactions (0)
Like

0

Love

0

Happy

0

Sad

0

Insightful

0

Comments / thoughts (0)
Add a comment

You must be logged in to leave a comment. Sign in or register now.